Among these signaling pathways, epidermal growth factor receptor (EGFR), insulin-like growth factor receptor (IGFR), tropomyosin receptor kinases (Trk), transforming growth factor-β (TGF-β) and the Hippo pathway have been shown to regulate anoikis resistance in glioma. This evidence concerns the gene TGFB1 and glioma.